Model
Edge
Pharmaceutical Product Development, LLC
0001003124
Filing type
8-K
Filing date
Dec 4, 2011
Updated
Dec 5, 2011 ยท 8:39 AM
Copy reference
Filing
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Amendments to Articles of Incorporation or Bylaws
Exhibits
EX-3.1
AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY
EX-99.1
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Amendments to Articles of Incorporation or Bylaws